In 2023, the Europe hospital-acquired disease testing market was valued at $3,408.5 million. According to IMARC Group, this market is projected to expand significantly, reaching $12,448.7 million by 2032. This growth represents a compound annual growth rate (CAGR) of 15.02% from 2024 to 2032. https://www.imarcgroup.com/europe-hospital-acquired-disease-testing-market